DGAP-News

aap Implantate AG: 30% sales growth in trauma in the first quarter of 2017

DGAP-News: aap Implantate AG / Key word(s): Preliminary Results/Quarter Results aap Implantate AG: 30% sales growth in trauma in the first quarter of 2017 24.04.2017 / 10:35 The issuer is solely responsible for the content of this announcement. aap Implantate AG ("aap") made a successful start in financial year 2017 as a pure player in trauma with significant sales growth. According to preliminary figures, trauma sales rose in the first three months of the current year compared to the corresponding period in the last year by 30% to EUR 2.9 million (Q1/2016: EUR 2.2 million). Overall, aap increased total sales in the first quarter of 2017 in comparison to the first three months of last year by 23% to EUR 3.1 million (Q1/2016: EUR 2.5 million). Thereby the company realized a value slightly above the guidance provided in February of EUR 1.8 million to EUR 2.8 million.

Sales

In EUR million	Q1/2017	Q1/2016	Change on year
Trauma thereof North America and Europe thereof RoW	2.9 2.1 0.8	2.2 1.8 0.4	+30% +16% +87%
Other (mainly discontinued activities)	0.2	0.3	-33%
Sales	3.1	2.5	+23%